OneShot Renal Denervation Registry
NCT01844037 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2015-09-02
Summary
This is a multi-center, prospective registry designed to monitor the outcomes of renal denervation with the OneShot Device in a real-world patient population.
Conditions
Interventions
- DEVICE
-
OneShot Ablation System
Renal denervation
Sponsors & Collaborators
-
Medtronic Endovascular
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- Italy
Study Locations
More Related Trials
-
Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis
NCT06556407 ·Status: RECRUITING ·Phase: NA
-
Renal Denervation in Patients With Chronic Heart Failure & Renal Impairment Clinical Trial
NCT01392196 ·Status: TERMINATED ·Phase: NA
-
Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance Cardiaque
NCT02471729 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Renal Denervation in ADPKD- RDN-ADPKD Study
NCT05460169 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sympathetic Mapping/ Ablation of Renal Nerves Trial - Hemodialysis
NCT04872114 ·Status: UNKNOWN ·Phase: NA
-
Tolerance to Hemodialysis in Insulin-Requiring Diabetic Patients: BD vs AFB With Blood Volume Biofeedback
NCT01098149 ·Status: COMPLETED ·Phase: NA
-
Distal Renal Denervation
NCT02667912 ·Status: COMPLETED ·Phase: NA
-
Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension
NCT02444442 ·Status: COMPLETED ·Phase: NA
-
Renal Stenting With Distal Atheroembolic Protection
NCT00868972 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Renal Denervation in Patients With Chronic Heart Failure
NCT02085668 ·Status: WITHDRAWN ·Phase: NA
-
HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure
NCT02608632 ·Status: UNKNOWN ·Phase: PHASE2
-
REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions.
NCT05703620 ·Status: RECRUITING ·Phase: NA
-
Open Versus Endovascular Revascularization in Patients With End-stage Renal Disease
NCT03293589 ·Status: COMPLETED
-
A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)
NCT05326230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
NCT05880537 ·Status: RECRUITING
-
Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease
NCT06086470 ·Status: RECRUITING ·Phase: NA
-
Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy
NCT01881035 ·Status: TERMINATED ·Phase: NA
-
LEPU Renal Denervation System for Resistant Hypertension
NCT02536326 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiac Arrhythmia in Patients with End-Stage Renal Disease
NCT04841304 ·Status: ACTIVE_NOT_RECRUITING
-
Kidney Perfusion With or Without Absorption
NCT06374121 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study to Evaluate Renal Denervation Using Focused Ultrasound
NCT01704170 ·Status: COMPLETED ·Phase: NA
-
Post-Market Observational Study of Intra-Renal Drug Delivery
NCT00716404 ·Status: WITHDRAWN
-
Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.
NCT05834803 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis
NCT06024135 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of the CM-1500 During Hemodialysis
NCT05125848 ·Status: COMPLETED ·Phase: NA